Box 1

Scope and Contents note From the Collection: This is a collection of papers of W. Benson Harer which includes drug evaluations, correspondence, appointment books and accounting records, certificates, and patient records. The drug evaluation reports (1955-1960) include reports for Schering; Smith, Kline and French; Squibb; Merck and others. There are individual patient records c. 1930s-1960s. Collection contains 18 volumes (1948-1967) of appointment and meeting logs, as well as accounting records. Collection also contains a paper...

Scope and Contents note From the Collection: This is a collection of papers of W. Benson Harer which includes drug evaluations, correspondence, appointment books and accounting records, certificates, and patient records. The drug evaluation reports (1955-1960) include reports for Schering; Smith, Kline and French; Squibb; Merck and others. There are individual patient records c. 1930s-1960s. Collection contains 18 volumes (1948-1967) of appointment and meeting logs, as well as accounting records. Collection also contains a paper...

Scope and Contents

Includes paper by Dr. H. C. Carpenter titled "Simplified Management of Obsterical Malpresentations." Also includes photo of Dr. Wilbur E. Flannery, president of PA Medical Society from 1963-1964.

Scope and Contents

Correspondence between Dr. W. Benson Harer and Merck Sharp and Dohme research laboratories (now Merck Pharmaceuticals). Drug evaluations mentioned include the analgesic compound anileridine/"Leritine" (1957). Evaluations also include drug combinations Hydrodiuril with meprobamate and Hydrodiuril with ethisterone (1959-1960) for the treatment of "premenstrual tension syndrome," now known as premenstrual syndrome (PMS).

Scope and Contents

Correspondence between Dr. W. Benson Harer and The Squibb Institute for medical research (now Bristol Myers Squibb) regarding drug evaluations. Drugs evaluated include antipsychotic Vespazine Elixir (active ingredient fluphenazine), and "Naturetin" (benzydroflumethiazide) in combination with Prolixin (fluphenazine) for the treatment of edema and "premenstrual tension syndrome," now known as premenstrual syndrome (PMS).

Scope and Contents

Correspondence between Dr. W. Benson Harer and Smith Kline and French laboratories regarding drug evaluations and publications. Evaluations include "Vi-Sorbin" study of liquid vitamin B12 and vitamin B12 concentrations in pregnant women and mention of Combid Spansules for the treatment of nausea and vomiting in early pregnancy.

Scope and Contents

Correspondence between Dr. W. Benson and Eaton Laboratories regarding drug evaluations for "Furoxone" (furazolidone) vaginal suppositories and powder for the treatment of trichomonas vaginalis and vaginitis.

Scope and Contents

Statement and agreement for investigational use of Imferon (iron dextran) for the treatment of anemia.

Scope and Contents

Correspondence between Dr. W. Benson Harer and the Schering corporation regarding drug evaluations. Evaluations include CMR-795/SCH-6503 and ethisterone compound for dysmenorrhea and "premenstrual tension syndrome," now known as premenstrual syndrome (PMS). Evaluations also include Tindal (acetophenazine) for anti-anxiety and antiemetic properties. Reports on the use of tranquilizing drugs SCH-3940 and SCH-6894 in labor is included.

Scope and Contents

Letter from Dr. W. Benson Harer inviting a patient to join a clinical trial.